Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine

Figure 4

The response of cutaneous myeloid sarcoma (MS) to treatment with azacitidine. An MS located at the left groin before the first (6th in total) cycle of azacitidine retreatment (a). Before the second (7th in total) cycle (b). After the second cycle (c). An MS on the left cheek before the first cycle (d). Before the second cycle (e). After the second cycle (f).

(a)

(b)

(c)

(d)

(e)

(f)